Add to Favorites Newsroom RSS Share
Buffalo, NY USA

Our News on Newswise

Roswell Park Cancer Institute Named a U.S. News ‘Best Hospital’ For Cancer


Roswell Park Cancer Institute has been named a 2017–18 Best Hospital for cancer by U.S. News & World Report. The Buffalo, N.Y., comprehensive cancer center was ranked by the news outlet as 33rd among nearly 900 cancer hospitals reviewed...
8-Aug-2017 12:05 AM EDT Add to Favorites

FDA Awards Orphan Status to Brain Cancer Vaccine Developed at Roswell Park Cancer Institute


The U.S. Food and Drug Administration has awarded orphan drug status to SurVaxM, a promising immunotherapy vaccine developed at Roswell Park Cancer Institute and being studied as a treatment for glioblastoma, a type of brain cancer.
7-Aug-2017 6:05 PM EDT Add to Favorites

Spirit of EAGLES Event Focused on Cancer in Native Communities Coming to Niagara Falls, NY in September


Roswell Park Cancer Institute and the Mayo Clinic Cancer Center are jointly hosting the 10th annual Spirit of EAGLES: Changing Patterns of Cancer in Native Communities conference, to be held Sept. 21–24 in Niagara Falls, New York.
31-Jul-2017 5:05 PM EDT Add to Favorites

Surgery and High-Dose SBRT Radiation Can Be Combined to Treat Kidney Cancer, Roswell Park Researchers Show

A new study from Roswell Park Cancer Institute reporting the findings of the first clinical trial to evaluate the immune effects of high-dose radiation therapy followed by surgery in patients with advanced kidney cancer may also set the stage for...
19-Jun-2017 4:55 PM EDT Add to Favorites

Roswell Park-Led Research Updates Data on Lenalidomide Maintenance for Patients with Multiple Myeloma


Dr. Philip McCarthy of Roswell Park Cancer Institute presents updated findings on CALGB/ECOG 100104 study of lenalidomide maintenance therapy for multiple myeloma, adjusting data to account for crossover effect.
6-Jun-2017 12:05 PM EDT Add to Favorites

Roswell Park’s Dr. Kunle Odunsi Gives Update on Ovarian Cancer Immunotherapy Study at ASCO Annual Meeting


Dr. Kunle Odunsi of Roswell Park Cancer Institute presented an update about an ongoing clinical trial involving T-cell engineering to treat advanced ovarian cancer at the ASCO Annual Meeting in Chicago.
6-Jun-2017 12:05 PM EDT Add to Favorites

Predictive Tool Developed by Roswell Park-OmniSeq Team Accurately Reflects Response to Checkpoint Inhibition


Roswell Park and OmniSeq report that a custom algorithm they developed based on a 54-gene signature accurately predicted response to anti-PD-L1 treatment in 90% of the cases they analyzed.
6-Jun-2017 12:05 PM EDT Add to Favorites

Researchers Report Encouraging Results From Combination Therapy in Hodgkin Lymphoma


The authors of a phase II clinical study report that combination therapy with brentuximab vedotin and gemcitabine in patients is “highly active" regimen for patients with Hodgkin lymphoma.
6-Jun-2017 11:05 AM EDT Add to Favorites

Our Experts on Newswise

Roswell Park: Racial Disparities From Cervical Cancer Are a Wake-Up Call

25-Jan-2017 10:05 AM EST

Dr. Igor Puzanov of @RoswellPark Cancer Institute Avail. To Comment on Chan/Zuckerberg $30b Pledge for #Medicalresearch

22-Sep-2016 3:05 PM EDT

Roswell Park's Dr. James Marshall Available to Interpret, Comment on Who Statement on Processed Meats and Cancer Risk

27-Oct-2015 5:05 PM EDT

Cancer-Specific Clinical Research Center: New Frontiers in Research at Roswell Park

Clinical trials are the frontier for targeted cancer drugs. Roswell Park Cancer Institute recently opened one of only a few clinical research centers in the U.S. focused exclusively on cancer. The Clinical Research Center, under the direction of...
4-Apr-2008 1:00 PM EDT

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact to configure this module.

Chat now!